Legal Opinion
Amgen Inc. v. Sandoz Inc.
Court of Appeals for the Federal Circuit
Decided May 8, 2019No. 2018-1551; 2018-1552PublishedCited by 21 opinions
1Opinion of the Court
Lourie, Circuit Judge.
*1025 Amgen Inc. and Amgen Manufacturing Ltd. (collectively, "Amgen") appeal from two decisions of the United States District Court for the Northern District of California in two patent infringement actions brought by Amgen under the Biologics Price Competition and Innovation Act ("BPCIA"), 42 U.S.C. § 262 (2012). The court construed claims of U.S. Patents 6,162,427 (the " '427 patent") and 8,940,878 (the " '878 patent"), Amgen Inc. v. Sandoz Inc. , No. 14-CV-04741-RS, 2016 WL 4137563 (N.D. Cal. Aug. 4, 2016) (" Claim Construction Order "), and granted summary judgment of…
2Cases cited31 opinions
- Dietz v. BouldinSupreme Court of the United States · 2016
- Victoria Zetwick v. County of YoloCourt of Appeals for the Ninth Circuit · 2017
- Teva Pharm. United States, Inc. v. Sandoz, Inc.Supreme Court of the United States · 2015
- Lucent Technologies, Inc. v. Gateway, Inc.Court of Appeals for the Federal Circuit · 2009
- Smithkline Diagnostics, Inc. v. Helena Laboratories Corporation, Defendant/cross-AppellantCourt of Appeals for the Federal Circuit · 1989
26 more not listed; retrieve them via the Exa API.
3Cited by21 opinions
- Natera, Inc. v. Neogenomics Laboratories, Inc.Court of Appeals for the Federal Circuit · 2024
- Nexstep, Inc. v. Comcast Cable Communications, LLCCourt of Appeals for the Federal Circuit · 2024
- George v. SmithDistrict Court, W.D. Wisconsin · 2006
- Biogen International Gmbh v. Banner Life Sciences LLCCourt of Appeals for the Federal Circuit · 2020
- AZURITY PHARMACEUTICALS, INC. v. AMNEAL PHARMACEUTICALS LLCDistrict Court, D. New Jersey · 2022
16 more not listed; retrieve them via the Exa API.